![Ari Shomair](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Ari Shomair
Corporate Officer/Principal presso POINT Biopharma, Inc. (United States)
Profilo
Ariel Shomair is currently the Vice President of Corporate Affairs & Strategy at POINT Biopharma, Inc. in the United States.
Previously, he worked as the Chief of Staff at POINT Biopharma Global, Inc.
Posizioni attive di Ari Shomair
Società | Posizione | Inizio |
---|---|---|
POINT Biopharma, Inc. (United States)
![]() POINT Biopharma, Inc. (United States) Miscellaneous Commercial ServicesCommercial Services Part of POINT Biopharma Global, Inc., POINT Biopharma, Inc. (United States) develops next-generation radioligand therapies for the treatment of cancer. The company is based in Indianapolis, IN. Joe McCann has been the CEO of the company since 2019. POINT Biopharma, Inc. (United States was acquired by Therapeutics Acquisition Corp. on June 30, 2021 for $578.95 million. | Corporate Officer/Principal | - |
Precedenti posizioni note di Ari Shomair
Società | Posizione | Fine |
---|---|---|
POIT BIOP | Public Communications Contact | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
POIT BIOP | Health Technology |
Aziende private | 1 |
---|---|
POINT Biopharma, Inc. (United States)
![]() POINT Biopharma, Inc. (United States) Miscellaneous Commercial ServicesCommercial Services Part of POINT Biopharma Global, Inc., POINT Biopharma, Inc. (United States) develops next-generation radioligand therapies for the treatment of cancer. The company is based in Indianapolis, IN. Joe McCann has been the CEO of the company since 2019. POINT Biopharma, Inc. (United States was acquired by Therapeutics Acquisition Corp. on June 30, 2021 for $578.95 million. | Commercial Services |
- Borsa valori
- Insiders
- Ari Shomair